WallStreetZenWallStreetZen

NASDAQ: KTTA
Pasithea Therapeutics Corp Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Pasithea Therapeutics earnings were -$13.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest KTTA earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$3.2M, up 5.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, KTTA reported annual earnings of -$13.9M, with -12.9% growth.

KTTA earnings history

Current Revenue
$0.0
Current Earnings
-$13.9M
Current Profit Margin
0%

KTTA Return on Equity

Current Company
-81%
Current Industry
-2%
Current Market
34.1%
KTTA's Return on Equity (-81%)... subscribe to Premium to read more.
High Return on Equity Performance

KTTA undefined

Current Company
-74.4%
Current Industry
-0.4%
KTTA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when KTTA announces earnings.

KTTA undefined

Current Company
-93.04%
Current Industry
5.9%
KTTA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KTTA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
KTTA-$13.26M-$13.90MN/A-$12.69
ADIL-$13.20M-$13.20MN/A-$2.72
DRMA-$12.29M-$12.29MN/A-$8.03
AEON$42.10M$42.01MN/A$77.74
SONN-$9.19M-$9.43MN/A-$10.19
View Top Biotech Stocks

Pasithea Therapeutics Earnings Reports & History FAQ

What were Pasithea Therapeutics's earnings last quarter?

Pasithea Therapeutics (NASDAQ: KTTA) reported Q4 2024 earnings per share (EPS) of -$2.41, up 46.92% year over year. Total KTTA earnings for the quarter were -$3.18 million. In the same quarter last year, Pasithea Therapeutics's earnings per share (EPS) was -$4.54.

If you're new to stock investing, here's how to buy Pasithea Therapeutics stock.

Is Pasithea Therapeutics profitable or losing money?

As of the last Pasithea Therapeutics earnings report, Pasithea Therapeutics is currently losing money. Pasithea Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$13.90 million, a 12.89% decrease year over year.

What was KTTA's earnings growth in the past year?

As of Pasithea Therapeutics's earnings date in Q2 2025, Pasithea Therapeutics's earnings has grown year over year. KTTA earnings in the past year totalled -$13.90 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.